281 related articles for article (PubMed ID: 35158472)
1. Serum neurofilament light chain correlates with myelin and axonal magnetic resonance imaging markers in multiple sclerosis.
Yik JT; Becquart P; Gill J; Petkau J; Traboulsee A; Carruthers R; Kolind SH; Devonshire V; Sayao AL; Schabas A; Tam R; Moore GRW; Li DKB; Stukas S; Wellington C; Quandt JA; Vavasour IM; Laule C
Mult Scler Relat Disord; 2022 Jan; 57():103366. PubMed ID: 35158472
[TBL] [Abstract][Full Text] [Related]
2. In vivo characterization of cortical and white matter neuroaxonal pathology in early multiple sclerosis.
Granberg T; Fan Q; Treaba CA; Ouellette R; Herranz E; Mangeat G; Louapre C; Cohen-Adad J; Klawiter EC; Sloane JA; Mainero C
Brain; 2017 Nov; 140(11):2912-2926. PubMed ID: 29053798
[TBL] [Abstract][Full Text] [Related]
3. Postmortem quantitative MRI disentangles histological lesion types in multiple sclerosis.
Galbusera R; Bahn E; Weigel M; Schaedelin S; Franz J; Lu PJ; Barakovic M; Melie-Garcia L; Dechent P; Lutti A; Sati P; Reich DS; Nair G; Brück W; Kappos L; Stadelmann C; Granziera C
Brain Pathol; 2023 Nov; 33(6):e13136. PubMed ID: 36480267
[TBL] [Abstract][Full Text] [Related]
4. Deficient MWF mapping in multiple sclerosis using 3D whole-brain multi-component relaxation MRI.
Kitzler HH; Su J; Zeineh M; Harper-Little C; Leung A; Kremenchutzky M; Deoni SC; Rutt BK
Neuroimage; 2012 Feb; 59(3):2670-7. PubMed ID: 21920444
[TBL] [Abstract][Full Text] [Related]
5. Diffusivity in multiple sclerosis lesions: At the cutting edge?
Klistorner A; Wang C; Fofanova V; Barnett MH; Yiannikas C; Parratt J; You Y; Graham SL
Neuroimage Clin; 2016; 12():219-26. PubMed ID: 27489769
[TBL] [Abstract][Full Text] [Related]
6. Effect of switching from glatiramer acetate 20 mg/daily to glatiramer acetate 40 mg three times a week on gray and white matter pathology in subjects with relapsing multiple sclerosis: A longitudinal DTI study.
Zivadinov R; Bergsland N; Hagemeier J; Tavazzi E; Ramasamy DP; Durfee J; Cherneva M; Carl E; Carl J; Kolb C; Hojnacki D; Weinstock-Guttman B
J Neurol Sci; 2018 Apr; 387():152-156. PubMed ID: 29571854
[TBL] [Abstract][Full Text] [Related]
7. Global loss of myelin water over 5 years in multiple sclerosis normal-appearing white matter.
Vavasour IM; Huijskens SC; Li DK; Traboulsee AL; Mädler B; Kolind SH; Rauscher A; Moore GW; MacKay AL; Laule C
Mult Scler; 2018 Oct; 24(12):1557-1568. PubMed ID: 28782447
[TBL] [Abstract][Full Text] [Related]
8. Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity.
Kuhle J; Barro C; Disanto G; Mathias A; Soneson C; Bonnier G; Yaldizli Ö; Regeniter A; Derfuss T; Canales M; Schluep M; Du Pasquier R; Krueger G; Granziera C
Mult Scler; 2016 Oct; 22(12):1550-1559. PubMed ID: 26754800
[TBL] [Abstract][Full Text] [Related]
9. Evidence of progressive tissue loss in the core of chronic MS lesions: A longitudinal DTI study.
Klistorner A; Wang C; Yiannikas C; Parratt J; Dwyer M; Barton J; Graham SL; You Y; Liu S; Barnett MH
Neuroimage Clin; 2018; 17():1028-1035. PubMed ID: 29387524
[TBL] [Abstract][Full Text] [Related]
10. Comparing MRI metrics to quantify white matter microstructural damage in multiple sclerosis.
Lipp I; Jones DK; Bells S; Sgarlata E; Foster C; Stickland R; Davidson AE; Tallantyre EC; Robertson NP; Wise RG; Tomassini V
Hum Brain Mapp; 2019 Jul; 40(10):2917-2932. PubMed ID: 30891838
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Normal-Appearing White Matter in Multiple Sclerosis Using Direct Visualization of Short Transverse Relaxation Time Component (ViSTa) Myelin Water Imaging and Gradient Echo and Spin Echo (GRASE) Myelin Water Imaging.
Choi JY; Jeong IH; Oh SH; Oh CH; Park NY; Kim HJ; Lee J
J Magn Reson Imaging; 2019 Apr; 49(4):1091-1098. PubMed ID: 30240519
[TBL] [Abstract][Full Text] [Related]
12. White matter and lesion T1 relaxation times increase in parallel and correlate with disability in multiple sclerosis.
Parry A; Clare S; Jenkinson M; Smith S; Palace J; Matthews PM
J Neurol; 2002 Sep; 249(9):1279-86. PubMed ID: 12242554
[TBL] [Abstract][Full Text] [Related]
13. Clinical and MRI correlates of CSF neurofilament light chain levels in relapsing and progressive MS.
Damasceno A; Dias-Carneiro RPC; Moraes AS; Boldrini VO; Quintiliano RPS; da Silva VAPG; Farias AS; Brandão CO; Damasceno BP; Dos Santos LMB; Cendes F
Mult Scler Relat Disord; 2019 May; 30():149-153. PubMed ID: 30772673
[TBL] [Abstract][Full Text] [Related]
14. Quantification of normal-appearing white matter tract integrity in multiple sclerosis: a diffusion kurtosis imaging study.
de Kouchkovsky I; Fieremans E; Fleysher L; Herbert J; Grossman RI; Inglese M
J Neurol; 2016 Jun; 263(6):1146-55. PubMed ID: 27094571
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal microstructural MRI markers of demyelination and neurodegeneration in early relapsing-remitting multiple sclerosis: Magnetisation transfer, water diffusion and g-ratio.
York EN; Meijboom R; Thrippleton MJ; Bastin ME; Kampaite A; White N; Chandran S; Waldman AD;
Neuroimage Clin; 2022; 36():103228. PubMed ID: 36265199
[TBL] [Abstract][Full Text] [Related]
16. Quantitative susceptibility mapping of the normal-appearing white matter as a potential new marker of disability progression in multiple sclerosis.
Pietroboni AM; Colombi A; Contarino VE; Russo FML; Conte G; Morabito A; Siggillino S; Carandini T; Fenoglio C; Arighi A; De Riz MA; Arcaro M; Sacchi L; Fumagalli GG; Bianchi AM; Triulzi F; Scarpini E; Galimberti D
Eur Radiol; 2023 Aug; 33(8):5368-5377. PubMed ID: 36562783
[TBL] [Abstract][Full Text] [Related]
17. Diffusion tensor magnetic resonance imaging in multiple sclerosis.
Filippi M; Cercignani M; Inglese M; Horsfield MA; Comi G
Neurology; 2001 Feb; 56(3):304-11. PubMed ID: 11171893
[TBL] [Abstract][Full Text] [Related]
18. Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI.
Cercignani M; Bozzali M; Iannucci G; Comi G; Filippi M
J Neurol; 2002 Jul; 249(7):875-83. PubMed ID: 12140672
[TBL] [Abstract][Full Text] [Related]
19. A 24-month advanced magnetic resonance imaging study of multiple sclerosis patients treated with alemtuzumab.
Vavasour IM; Tam R; Li DK; Laule C; Taylor C; Kolind SH; MacKay AL; Javed A; Traboulsee A
Mult Scler; 2019 May; 25(6):811-818. PubMed ID: 29663845
[TBL] [Abstract][Full Text] [Related]
20. Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study.
Oreja-Guevara C; Rovaris M; Iannucci G; Valsasina P; Caputo D; Cavarretta R; Sormani MP; Ferrante P; Comi G; Filippi M
Arch Neurol; 2005 Apr; 62(4):578-84. PubMed ID: 15824256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
